NASDAQ · Medical - Devices

CLPT (CLPT) Stock

$14.31 -3.96% NASDAQ: CLPT Healthcare

Valuation

MetricValue
Price$14.31
Market Cap$429.15M
P/E Ratio-13.19
P/B Ratio43.11
P/S Ratio11.04
EPS (TTM)$0.00
52-Week High$30.10
52-Week Low$8.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-188.09%
ROA-39.85%
ROCE-40.62%
Gross Margin-64.86%
Operating Margin-64.86%
Net Margin-81.76%
Debt/Equity5.93
Current Ratio5.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$16.0M$21.0M$24.0M$31.0M$37.0M
Operating Profit$-13.0M$-16.0M$-22.0M$-20.0M$-24.0M
Net Profit$-14.0M$-16.0M$-22.0M$-19.0M$-26.0M
EPS$-0.69$-0.68$-0.90$-0.70$-0.90
Op Margin-82.0%-79.5%-93.7%-62.9%-65.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$66.0M$55.0M$43.0M$39.0M$98.0M
Total Liabilities$17.0M$19.0M$21.0M$14.0M$70.0M
Cash$54.0M$28.0M$23.0M$20.0M$46.0M
Borrowings$12.0M$12.0M$14.0M$4.0M$58.0M

Latest News

Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing MT Newswires · Jul 2, 2026 ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? Zacks · Jun 18, 2026 ClearPoint Neuro Shares Jump as FDA Progress for UniQure Therapy Highlights Platform Value InvestorsHub · Jun 17, 2026 ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint ACCESS Newswire · May 27, 2026 How The ClearPoint Neuro (CLPT) Narrative Is Shifting On Partnerships Valuation And FDA Risks Simply Wall St. · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-16.0M$-14.0M$-9.0M$-24.0M
Investing Cash Flow$0$-11.0M$8.0M$-1.0M$0
Financing Cash Flow$0$0$0$0$-2.0M
Net Cash Flow$34.0M$-26.0M$-4.0M$-3.0M$27.0M
Free Cash Flow$-13.0M$-16.0M$-14.0M$-9.0M$-24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.38
EV / EBITDA-18.28
FCF Yield-6.71%
Quick Ratio3.87
Interest Coverage-7.68
Return 1Y25.13%
Return 3Y113.72%
Return 5Y-4.60%

Ownership

Insiders Held5.48%
Institutions Held50.62%
Institutions Float Held53.55%
Institutional HolderSharesReport Date
Blackrock Inc.2,082,7502026-03-31
MAK Capital One LLC1,901,4892026-03-31
Vanguard Capital Management LLC1,243,6152026-03-31
Geode Capital Management, LLC705,7202026-03-31
State Street Corporation679,8192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKBA $0.98 +3.77% -45.00 $262.97M 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CTKB $4.69 +1.52% -7.25 $605.68M 0.00%
LAB $0.67 +3.51% -5.30 $263.57M 0.00%

About CLPT

CLPT is led by CEO Joseph Michael Burnett, employs 115 people, headquartered in US, publicly traded since 2012.

CLPT stock trades at $14.31 with a market capitalization of $429.15M. The stock is valued at a price-to-earnings (P/E) ratio of -13.19, price-to-book of 43.11, price-to-sales of 11.04. Over the past 52 weeks the stock has ranged between $8.27 and $30.10, and currently trades 52.5% below its 52-week high.

On profitability, CLPT generates a return on equity (ROE) of -188.09%, return on capital employed of -40.62%, an operating margin of -64.86%, a net profit margin of -81.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides